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Abstract 
Background: Medical quality registers are useful sources of knowledge about diseases and the health services. 
However, there are challenges in obtaining valid and reliable data. This study aims to assess the reliability in a national 
medical quality register.
Methods: We randomly selected 111 patients having had a stroke in 2012. An experienced stroke nurse completed 
the Norwegian Stroke Register paper forms for all 111 patients by review of the medical records. We then extracted all 
registered data on the same patients from the Norwegian Stroke Register and calculated Cohen’s kappa and Gwet’s 
AC1 with 95 % confidence intervals for 51 nominal variables and Cohen’s quadratic weighted kappa and Gwet’s AC2 
for three ordinal variables. For two time variables, we calculated the Intraclass Correlation Coefficient.
Results: Substantial to excellent reliability (kappa > 0.60/AC1 > 0.80) was observed for most variables related to 
past medical history, functional status, stroke subtype and discharge destination. Although excellent reliability was 
observed for time of stroke onset (ICC 0.93), this variable was hampered with a substantial amount of missing values. 
Some variables related to treatment and examinations in hospital displayed low levels of agreement. This applies to 
heart rate monitoring (kappa 0.17/AC1 0.46), swallowing test performed (kappa 0.19/AC1 0.27) and mobilized out of 
bed within 24 h after admission (kappa 0.04/AC1 −0.11).
Conclusion: A majority of the variables in The Norwegian Stroke Register have substantial to excellent reliability. The 
problem areas seem to be the lack of completeness in the time variable indicating stroke onset and poor reliability in 
some variables concerning examinations and treatment received in hospital.
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Background
In many countries, there has been an increasing interest 
in medical quality registers as a tool for improving the 
quality of care and as sources of knowledge about dis-
eases and of the health services. Consequently, a number 
of local, regional and national medical quality registers 
have been established. There seems to be agreement on 
the importance of such registers. However, there are 
challenges in obtaining valid and reliable data.
Few studies have investigated the validity of stroke 
registers [1], and these typically focus on calculating 
measures of completeness. Although some studies have 
investigated the reliability of selected key variables in reg-
isters [2, 3], we are aware of only one study assessing the 
reliability of all the variables in a stroke-specific register 
[4]. Reeves et al. found excellent inter-rater reliability for 
many variables, but several variables in need of improve-
ment were also identified. These include stroke onset 
time, stroke team consultation, time of initial brain imag-
ing and discharge destination.
Since 1 January 2012 all Norwegian hospitals are 
requested by law to report medical data on all hospital-
ized patients who fulfill the WHO criteria [5] for an acute 
stroke diagnosis to the Norwegian Stroke Register [6]. 
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In the present study, we assessed the reliability of all the 
variables in the Norwegian Stroke Register by studying 
inter-rater reliability in a random sample of 111 patients.
Methods
The Norwegian Stroke Register
All hospitalized cases of acute stroke are to be reported 
to the Norwegian Stroke Register, irrespective of whether 
the patient was treated in a stroke unit or not. Data are 
initially registered on paper forms locally at the hospi-
tals by dedicated and trained physicians and nurses, who 
subsequently enter data into the Stroke Register by use 
of a web based form. The completion of the registra-
tion process at the hospitals often takes place after the 
patient was discharged by look-up in the electronic medi-
cal records. As there are one or more registrars at each 
stroke unit or hospital, depending on the size of the unit, 
the reporting nurse or physician may or may not have 
been involved in the treatment of the patient.
The register contains person identifiable data on the 
patients’ functional status before the stroke, past medi-
cal history, the use of drugs prior to hospitalization and 
at discharge, clinical findings on admission to hospital, 
diagnostic procedures, treatment received during hospi-
talization and dates and times for stroke onset, admission 
to hospital and discharge. A user manual provides defini-
tions of the variables and data entries [7].
Data collection
The study population consists of patients hospitalized in 
one of four hospitals in Central Norway (St. Olav’s Uni-
versity Hospital, Levanger Hospital, Kristiansund Hospi-
tal and Ålesund Hospital). The four hospitals were chosen 
as they had reported data to the Stroke Register since 
2004, and had by 2012 established well-functioning data 
collection routines. A total of 1253 patients were regis-
tered with an acute stroke diagnosis (ICD-10 codes I61, 
I63, I64) in the Norwegian Patient Register in the period 
of 1 April–31 December 2012 in the four hospitals under 
study. From these registrations, we selected 120 patients 
using a random number-generator.
An experienced nurse working at a stroke unit in one 
of the hospitals under study (St. Olav’s University Hospi-
tal) filled in the Norwegian Stroke Register paper forms 
for the 120 patients by a review of the patients’ medical 
records. She did not work at the stroke unit in 2012, and 
consequently did not perform the original registrations. 
The nurse was given access to all necessary information, 
including results of diagnostic tests and examinations 
and laboratory tests. The data collection was done during 
May–June 2014. The nurse did not receive any particu-
lar training; the only guidance she received was the Nor-
wegian Stroke Register User Manual which is accessible 
to all registrars. The reason for this was that we wanted 
to mimic a “real world” situation as far as possible. The 
professional background of the nurse and the situation 
in which the registrations took place were considered 
typical to the actual registration procedures at hospitals 
around the country.
When extracting data from the Norwegian Stroke Reg-
ister, 9 of the 120 cases were not found. Consequently, 
the sample size was reduced to 111 patients.
Statistical analysis
The sample size was determined on the basis of recom-
mended sample size calculations for the kappa statistic. 
The Goodness-of-fit approach by Donner and Eliasziw 
[8] states that based on alpha and beta error rates of 0.05 
and 0.2, respectively, when testing for a statistical differ-
ence between moderate (0.40) and excellent (0.90) kappa 
values, sample size estimates range from 13 to 66. Our 
sample of 111 patients thus seems appropriate to detect 
generalizable estimates of inter-rater reliability.
For all nominal variables the inter-rater agreement 
is presented in terms of observed agreement, Cohen’s 
kappa and Gwet’s AC1 with 95  % confidence intervals 
(CI) [9–11]. Cases with missing values were excluded. 
For the three ordinal variables we used the quadratic 
weighted kappa and AC2, and the category “unknown” 
was excluded.
The kappa statistic is influenced by the trait preva-
lence and rater bias [12, 13]. In situations where a large 
proportion of the ratings are either positive or nega-
tive, the unbalanced prevalence of the trait will lead to a 
reduced kappa coefficient. In situations where there is a 
systematic difference between the two raters’ tendencies 
to make particular ratings, the kappa coefficient may be 
inflated. Gwet’s AC1 and AC2, however, is not affected by 
trait prevalence or rater bias [11].
When interpreting chance-corrected agreement, we 
use the criteria suggested by Landis and Koch [14], stat-
ing that a value between 0 and 0.20 implies slight agree-
ment, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 
substantial, and >0.80 excellent agreement. To aid inter-
pretation of the agreement coefficients, cross tables for 
all presented variables are included in Additional file  1: 
Appendix S1.
Time variables were re-calculated as minutes past mid-
night when the corresponding date variable was the same 
for both raters (nurse and Stroke Register). We calcu-
lated the Intraclass Correlation Coefficient (ICC) using 
a two-way random effects consistency ANOVA model. 
ICC assesses agreement by comparing the variability of 
different ratings of the same subject to the total variation 
across all subjects [15]. The interpretation of the mag-
nitude of ICC is similar to that of kappa; a coefficient of 
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0 means no agreement and 1 means full agreement. In 
addition to the ICC estimates, we calculated the mean 
and standard deviation of the differences between the 
raters.
When reporting results, we have strived to fulfil the 
recommendations in the Guidelines for Reporting Reli-
ability and Agreement Studies by Kottner et al. [16]. We 
used IBM SPSS statistics 21 for building analysis files and 
for calculating ICC, and AgreeStat 2015.4 for calculating 
kappa, AC1 and AC2 statistics.
The study was approved by the Norwegian Directorate 
of Health and The Norwegian Data Protection Authority.
Results
The sample of 111 patients consisted of 53.2  % men, 
with mean age 73.1 years (SD 14.9). In comparison, the 
total population in the Norwegian Stroke Register in 
2012 consisted of 51.7 % men with mean age 74.1 years 
(no SD available) [17]. Additional file  2: Appendix S2 
shows the number of hospitalizations with stroke and 
sample size for each of the four hospitals included in the 
study.
The agreement was substantial to excellent (kappa 
>0.60/AC1 >0.80) for most variables concerning func-
tional status before stroke onset, past medical history 
and drug treatment prior to stroke onset (Table  1). For 
previous incidence of transient ischemic attack (TIA), the 
kappa of 0.54 indicated moderate agreement. However, 
an AC1 of 0.91 and an observed agreement of 91.9 % sug-
gested that this variable had a skewed trait distribution 
and hence an artificially low kappa coefficient.
The variable patient woke with stroke symptoms had 
a kappa coefficient of 0.28 and an AC1 of 0.49, indicat-
ing fair to moderate agreement. For the variable place of 
stroke onset a kappa of 0.58 was balanced by an AC1 of 
0.96 and an observed agreement of 96.4 %, thus the reli-
ability was considered to be good for this variable.
Variables describing FAST-symptoms (hemiparesis and 
speech problems) showed moderate to substantial agree-
ment (kappa 0.52–0.64/AC1 0.62–0.73), while agreement 
for other focal symptoms were moderate (kappa 0.37/
AC1 0.46). The variable describing side of symptom man-
ifestation showed substantial agreement (kappa 0.69/AC1 
0.73). Level of consciousness is an ordinal variable display-
ing substantial to excellent agreement (kappa 0.66/AC2 
0.93) (Table 2).
For variables concerning diagnostic imaging there was 
substantial to excellent agreement (kappa > 0.56/AC1 > 
0.82). However, the variable heart rate monitoring had 
slight to moderate agreement (kappa 0.17/AC1 0.46).
The variable mobilized out of bed within 24  h after 
admission had no better agreement than by chance 
(kappa 0.04/AC1 −0.11), and the variable swallowing test 
performed showed only slight to fair agreement (kappa 
0.19/AC1 0.27).
For the stroke subtype variable, there was close to per-
fect agreement (kappa 0.97/AC1 0.99).
All response options in the variable discharge destina-
tion indicated substantial agreement (kappa 0.69/AC1 
0.72) (Table  3). Drug treatment at discharge seemed to 
be varying in the level of agreement between the differ-
ent types of drug, from a kappa of 0.25/AC1 of 0.65 for 
Dipyridamole as the least reliable variable to kappa and 
AC1 > 0.90 for ADP receptor antagonist, ACE inhibi-
tor, A2 receptor blocker and statins as the most reliable 
variables.
There was a substantial amount of missing values in 
date (24.3 %) and time (58.6 %) of stroke onset in the data 
recorded by the nurse and in time of stroke onset in the 
Stroke Register (40.5 %). Time of hospital admission was 
missing in 13.5 % of the cases for the nurse and 2.7 % of 
the cases for the Stroke Register. As a consequence, only 
42 and 89 cases out of 111 were included in the calcula-
tion of ICC for stroke onset time and hospital admittance 
time, respectively (Table 4).
Both time variables had excellent agreement (ICC 
0.93–0.98) where there was a value recorded. However, 
the mean difference and variance between the raters were 
greater for stroke onset time than for hospital admission 
time, as was the level of incompleteness.
Discussion
Most of the variables in the Norwegian Stroke Regis-
ter appeared to have substantial to excellent reliability, 
including many of the variables related to past medical 
history, functional status before the stroke, discharge des-
tination, stroke subtype and drug treatment prior to the 
stroke. Variables related to focal symptoms and speech 
problems at admittance to hospital showed moderate 
agreement, while the variable describing whether the 
patient woke with symptoms indicated slight to moderate 
agreement. Furthermore, reliability was low for variables 
related to several examinations and clinical findings dur-
ing hospitalization, such as monitoring heart rate, test of 
swallowing function and whether the patient was mobi-
lized out of bed <24 h after admission.
When interpreting the results, for variables with sub-
stantial discrepancy between the kappa and AC1 coeffi-
cients, the variable was considered reliable where kappa 
was low and AC1 and observed agreement was high. In 
these cases the kappa coefficient was considered artifi-
cially low due to skewed trait prevalence. Distribution of 
trait prevalence for all variables is shown in Additional 
file 1: Appendix S1.
Time of stroke onset is a particularly important variable, 
as it is essential in determining eligibility for thrombolytic 
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therapy. In this study, time of stroke onset and admission 
to hospital indicated excellent agreement where such time 
was in fact registered. However, there was a large propor-
tion of missing values in these data. The data collection 
procedures in this study appear to have had some impact 
on the data completeness. For the nurse, using paper 
forms to fill in the data, there was a substantial amount of 
missing values in both date and time of stroke onset and 
in time of hospital admission. In the Stroke Register, on 
the other hand, time of stroke onset was the only date/
time-variable which was hampered with a high degree 
of missingness. A likely explanation is that the content in 
the Norwegian Stroke Register is collected via an online 
electronic form where the fields for stroke onset date and 
hospital admission date are mandatory fields. The time 
variables, however, are not mandatory.
Other studies have found a similar high degree of miss-
ingness when recording time of stroke onset [4, 18, 19]. 
Proposed suggestions to correct this weakness in the 
data have ranged from developing a real-time data col-
lection system for recording stroke onset time, to the use 
of standardized time windows instead of the actual hour/
minute of the onset [20]. Although this study indicated a 
high degree of reliability for the date and time variables, 
the results suggests that steps needs to be taken to ensure 
more complete recordings of time of stroke onset in the 
Norwegian Stroke Register.
The registration of stroke symptoms displayed moder-
ate levels of agreement. One can expect to see some vari-
ation in level of agreement for these types of variables, as 
they are to some extent based on subjective assessments 
and thereby inherently difficult to classify in a consistent 
Table 1 Inter-rater reliability for medical history, functional status prior to stroke onset and pre-hospital data
a Observed agreement calculated as concordant answers divided by N
b Ordinal data, estimate based on Cohen’s quadratic weighted kappa and Gwet’s AC2
N Obs.agr. (%)a Kappa (95 % CI) AC1 (95 % CI)
Past medical history
 Previous stroke 111 92.8 0.81 (0.69–0.94) 0.91 (0.85–0.97)
 Myocardial infarction 111 96.4 0.87 (0.75–0.99) 0.95 (0.90–1.00)
 Major cardiac interventions 111 92.8 0.66 (0.43–0.88) 0.92 (0.86–0.98)
 Atrial fibrillation 111 89.2 0.71 (0.56–0.86) 0.87 (0.79–0.94)
 Diabetes 109 97.2 0.92 (0.83–1.00) 0.96 (0.91–1.00)
 TIA (transient ischemic attack) 111 91.9 0.54 (0.27–0.81) 0.91 (0.85–0.97)
Drug treatment prior to stroke onset
 Aspirin (ASA) 110 97.3 0.94 (0.87–1.00) 0.95 (0.89–1.00)
 ADP receptor antagonist 110 98.2 0.74 (0.40–1.00) 0.98 (0.96–1.00)
 Dipyridamole 110 95.5 0.60 (0.28–0.92) 0.95 (0.91–0.99)
 Warfarin 111 98.2 0.93 (0.83–1.00) 0.98 (0.95–1.00)
 Diuretics 111 86.5 0.60 (0.42–0.78) 0.84 (0.76–0.92)
 ACE-inhibitor 110 98.2 0.91 (0.80–1.00) 0.98 (0.95–1.00)
 A2-receptor blocker 110 92.7 0.70 (0.52–0.89) 0.92 (0.86–0.98)
 Beta blocker 111 95.5 0.91 (0.82–0.99) 0.94 (0.90–0.99)
 Calcium channel blocker 109 94.5 0.74 (0.54–0.94) 0.94 (0.90–0.99)
 Statins 111 97.3 0.94 (0.87–1.00) 0.95 (0.90–1.00)
 Other drugs against hypertension 111 72.0 0.48 (0.34–0.61) 0.63 (0.51–0.74)
Functional status prior to stroke
 Housingb 110 98.2 0.88 (0.80–0.96) 0.97 (0.94–0.99)
 Functional mobilityb 104 98.1 0.83 (0.67–0.98) 0.98 (0.96–0.99)
 Marital status 111 75.7 0.62 (0.52–0.72) 0.69 (0.58–0.80)
 Living situation 106 91.0 0.84 (0.75–0.93) 0.89 (0.82–0.96)
 Toilet hygiene 111 88.3 0.44 (0.24–0.65) 0.87 (0.80–0.94)
 Dressing 111 87.4 0.55 (0.37–0.73) 0.85 (0.78–0.93)
On stroke onset
 Patient woke with stroke symptoms? 108 62.0 0.28 (0.11–0.44) 0.49 (0.35–0.62)
 Place of stroke onset 110 96.4 0.58 (0.21–0.96) 0.96 (0.92–1.00)
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manner [21]. A study investigating inter-rater reliability 
for clinical assessment of stroke found no better agree-
ment between clinicians assessing focal symptoms in the 
same patients than what we found in the present study 
[22].
Another problematic variable was the recording of 
heart rate monitoring. Almost all of the registrations 
in this variable fell within two categories; ECG alone or 
a combination of several modalities (ECG, telemetry, 
Holter monitoring). However, the poor level of agree-
ment suggests that a clarification of the response catego-
ries in this variable can be useful.
The Norwegian Stroke Register’s User Manual does 
not provide any criteria for recording whether swallow-
ing function was tested. Given the poor reliability of 
this variable, there seems to be some confusion as to the 
definition of such a test. For the variable mobilized out 
Table 2 Inter-rater reliability for symptoms, diagnostic procedures, treatment and stroke subtype
a Observed agreement calculated as concordant answers divided by N
b Ordinal data, estimate based on Cohen’s quadratic weighted kappa and Gwet’s AC2
N Obs.agr. (%)a Kappa (95 % CI) AC1 (95 % CI)
Symptoms at admission
 Hemiparesis face 108 79.6 0.64 (0.51–0.77) 0.72 (0.61–0.83)
 Hemiparesis legs 110 73.6 0.54 (0.41–0.68) 0.63 (0.51–0.75)
 Hemiparesis arms 109 80.0 0.62 (0.49–0.75) 0.73 (0.62–0.83)
 Speech problems 107 72.9 0.52 (0.37–0.66) 0.62 (0.50–0.75)
 Other focal symptoms 111 62.2 0.37 (0.22–0.53) 0.46 (0.33–0.59)
 Symptoms at right/left side 111 79.3 0.69 (0.58–0.79) 0.73 (0.64–0.84)
 Level of consciousnessb 109 95.8 0.66 (0.47–0.85) 0.93 (0.89–0.98)
Diagnostic imaging and examinations
 CT/MRI <24 h after admission 110 97.3 0.69 (0.39–0.99) 0.97 (0.94–1.00)
 Imaging of the stroke 109 87.2 0.77 (0.66–0.87) 0.84 (0.76–0.92)
 Imaging of intracranial vessels 110 91.0 0.56 (0.33–0.79) 0.90 (0.85–0.96)
 Imaging of extracranial vessels 110 83.6 0.71 (0.59–0.83) 0.82 (0.74–0.90)
 Imaging of the heart 111 89.2 0.68 (0.52–0.85) 0.88 (0.82–0.95)
 Heart rate monitoring 111 52.2 0.17 (0.03–0.31) 0.46 (0.35–0.57)
Treatment and diagnosis
 Anticoagulants as treatment 111 88.3 0.34 (0.04–0.60) 0.87 (0.80–0.94)
 Anticoagulants as prophylaxis 111 86.5 0.56 (0.36–0.76) 0.84 (0.76–0.92)
 Swallowing test performed 111 48.6 0.19 (0.09–0.30) 0.27 (0.12–0.43)
 Mobilized out of bed <24 h 110 21.8 0.04 (0.00–0.09) −0.11 (0.00–0.01)
 Stroke subtype 111 99.1 0.97 (0.90–1.00) 0.99 (0.97–1.00)
Table 3 Inter-rater reliability for discharge data
a Observed agreement calculated as concordant answers divided by N






111 74.8 0.69 (0.60–0.79) 0.72 (0.63–0.81)
Drug treatment at discharge
 Aspirin (ASA) 110 73.6 0.51 (0.38–0.64) 0.65 (0.54–0.76)
 ADP receptor 
antagonist
110 99.1 0.94 (0.83–1.00) 0.99 (0.97–1.00)
 Dipyridamole 110 71.0 0.25 (0.10–0.41) 0.65 (0.53–0.76)
 Warfarin 110 96.4 0.85 (0.70–0.99) 0.96 (0.92–0.99)
 Diuretics 110 88.2 0.60 (0.40–0.80) 0.86 (0.79–0.94)
 ACE-inhibitor 110 99.1 0.96 (0.90–1.00) 0.99 (0.97–1.00)
 A2-receptor 
blocker
110 93.6 0.75 (0.58–0.93) 0.93 (0.87–0.98)
 Beta blocker 110 94.5 0.87 (0.77–0.97) 0.93 (0.88–0.99)
 Calcium chan-
nel blocker
109 96.3 0.83 (0.66–0.99) 0.96 (0.92–0.99)
 Statins 110 96.4 0.93 (0.86–1.00) 0.95 (0.93–1.00)
Table 4 Intraclass correlation coefficient for two time vari-
ables
a Calculated as minutes past midnight
b Mean difference in minutes calculated as nurse minus Stroke Register
c Standard deviation of the difference
Variable N ICC (95 % CI) Mean diff.b SDc
Stroke onset time (min)a 42 0.93 (0.88–0.96) 26.38 121.60
Hospital admission time  
(min)a
89 0.98 (0.97–0.99) 0.45 64.50
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of bed <24  h after admission the raw data showed that 
the main difference is that the nurse chose the category 
“unknown” to a larger extent than the stroke register. This 
could indicate that for this variable, it is difficult to find 
clear information in the medical records. In further qual-
ity enhancement work, the Stroke Register should look 
into the possibility of better definitions or explanations of 
these variables.
This study has several limitations. First, differences in 
data collection methods between the nurse and the Stroke 
Register may have had an impact on the results. This is 
particularly applicable for the date variables, as these are 
mandatory fields in the electronic web-based form of the 
Norwegian Stroke Register, while the nurse using paper 
forms did not have any validation rules affecting her reg-
istrations. Second, the nurse recorded data for four dif-
ferent hospitals, while the stroke register contains data 
collected by one registrar per hospital. Third, the sam-
ple size is not sufficient to perform analyses at the level 
of each hospital. Finally, 2012 was the first year after the 
stroke register was established as a national register and 
most hospitals had limited experience with documenta-
tion in the medical records and registration in the register. 
Hence the results might improve in the future.
Additionally, when making inferences based on reliabil-
ity studies, there is an inherent challenge in determining 
whether discrepancies between the two raters’ registra-
tions are due to factors related to the quality of the hospi-
tal medical records, the quality of variables in the register 
or the quality of the registration work by the raters.
Conclusion
A majority of the variables in the Norwegian Stroke Reg-
ister have substantial to excellent reliability. The problem 
areas seem to be the level of incompleteness in the time 
variable related to stroke onset and poor reliability in 
some variables concerning examinations, clinical findings 
and treatment during hospitalization. The study points to 
ambiguous definitions of variables or response categories 
as well as difficulties in finding or interpreting informa-
tion in medical records as possible explanations to the 
discrepancies. Steps should be taken to improve the com-
pleteness and reliability of the variables in question.
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